A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

Clinical trial NCT00206284 · COMPLETED

Trial details

NCT number: NCT00206284
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

GERD Without Erosive Esophagitis

Start date: 2004-05-01
Enrollment: 1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.